Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Clinical Pharmacology and Therapeutics|August 8, 2006
Impact of the haplotype CYP3A4*16B harboring the Thr185Ser substitution on paclitaxel metabolism in Japanese patients with cancerYukiko Nakajima, Takashi Yoshitani, Hiromi Fukushima-Uesaka, et al.
Cancer Chemotherapy and Pharmacology|November 10, 2007
Impact of CYP3A4 haplotypes on irinotecan pharmacokinetics in Japanese cancer patientsKimie Sai, Yoshiro Saito, Hiromi Fukushima-Uesaka, et al.
Drug Metabolism and Pharmacokinetics|March 17, 2005
Genetic polymorphisms of UGT1A6 in a Japanese populationMayumi Saeki, Yoshiro Saito, Hideto Jinno, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 21, 2007
Haplotypes and a novel defective allele of CES2 found in a Japanese populationSu-Ryang Kim, Kimie Sai, Toshiko Tanaka-Kagawa, et al.
Cancer Chemotherapy and Pharmacology|September 23, 2009
Additive effects of drug transporter genetic polymorphisms on irinotecan pharmacokinetics/pharmacodynamics in Japanese cancer patientsKimie Sai, Yoshiro Saito, Keiko Maekawa, et al.
European Journal of Clinical Pharmacology|February 5, 2005
Haplotype structures of EPHX1 and their effects on the metabolism of carbamazepine-10,11-epoxide in Japanese epileptic patientsYukiko Nakajima, Yoshiro Saito, Kisho Shiseki, et al.
Pageof 7